J&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer Post author:Sam Post published:February 14, 2018 Post category:BioPharma Janssen got a little love from the FDA on Wednesday. Source: BioSpace You Might Also Like Genentech's $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire February 6, 2017 Nativis, Inc. Convenes Inaugural Ultra-Low Radio Frequency Energy Technology Advisory Board (TAB) Meeting March 13, 2017 Meet the 4 Biotechs That are Disrupting Healthcare November 13, 2017
Nativis, Inc. Convenes Inaugural Ultra-Low Radio Frequency Energy Technology Advisory Board (TAB) Meeting March 13, 2017
